Day: December 12, 2022

InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor

InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor

VANCOUVER, British Columbia, Dec. 12, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announces the Company has entered into a service contract (the “Contract”) with Brio Financial Group (“Brio”) to provide senior financial leadership and bookkeeping services. Pursuant to the Contract, Mr. Jonathan Tegge, a member of Brio, will assume the role of Interim Chief Financial Officer for the Company effective December 12, 2022. Brio is a financial and management consulting group based in Bridgewater, New Jersey. The firm provides outsourced financial management and financial reporting support to small and middle market entities. Currently, the team provides consulting...

Continue reading

Nurix Therapeutics Presents Positive Clinical Results from its Novel BTK Degrader (NX-2127) at the 64th American Society of Hematology (ASH) Annual Meeting

Nurix Therapeutics Presents Positive Clinical Results from its Novel BTK Degrader (NX-2127) at the 64th American Society of Hematology (ASH) Annual Meeting

Treatment with NX-2127 provides clinically meaningful responses in heavily pretreated chronic lymphocytic leukemia (CLL) patients regardless of Bruton’s tyrosine kinase (BTK) mutational status BTK mutations conferring resistance to both covalent and non-covalent BTK inhibitors remain susceptible to degradation by NX-2127 Nurix will host a Key Opinion Leader (KOL) webcast event at 9:30 pm ET today to review data presented at ASH and progress in its degrader portfolio SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today presented additional positive clinical data from its Phase 1 clinical trial of NX-2127 in two oral sessions by...

Continue reading

Northwestern Enterprises Ltd. Acquires Common Shares of Aura Minerals Inc.

Northwestern Enterprises Ltd. Acquires Common Shares of Aura Minerals Inc.

ROAD TOWN, British Virgin Islands, Dec. 12, 2022 (GLOBE NEWSWIRE) — Northwestern Enterprises Ltd. (“Northwestern”), a company beneficially owned by Paulo Carlos de Brito, announces that it has acquired 280,000 common shares (“Aura Shares”) of Aura Minerals Inc. (“Aura”) in normal course transactions on the Toronto Stock Exchange with the result that Northwestern owns or has control or direction over an aggregate of 38,136,105 Aura Shares, representing approximately 53.0671% of the issued and outstanding Aura Shares. The 280,000 Aura Shares were purchased at an average of $7.70 per Aura Share, for an aggregate of $2,156.000. The acquisition of the Aura Shares was completed as part of Northwestern’s ongoing review of its investment holdings, and to permit it to increase its ownership position in Aura. Northwestern intends to evaluate...

Continue reading

Brookfield Corporation Announces Pricing of C$1 Billion of Medium-Term Notes

Brookfield Corporation Announces Pricing of C$1 Billion of Medium-Term Notes

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATES BROOKFIELD, NEWS, Dec. 12, 2022 (GLOBE NEWSWIRE) — Brookfield Corporation (NYSE: BN, TSX: BN) today announced the pricing of a public offering of C$1 billion aggregate principal amount of medium-term notes (“notes”) due December 2032, which will bear interest at a rate of 5.431% per annum. The notes are expected to be assigned a credit rating of A- by Standard & Poor’s, A- by Fitch, A3 by Moody’s and A (low) by DBRS. Brookfield Corporation intends to use the net proceeds from the sale of the notes for general corporate purposes. The notes are being offered through a syndicate of agents led by CIBC Capital Markets, RBC Capital Markets, Scotiabank, BMO Capital Markets, National Bank Financial Markets and TD Securities. The notes are being...

Continue reading

Cardinal Energy Ltd. Announces Monthly Dividend for December

Cardinal Energy Ltd. Announces Monthly Dividend for December

CALGARY, Alberta, Dec. 12, 2022 (GLOBE NEWSWIRE) — Cardinal Energy Ltd. (“Cardinal” or the “Company“) (TSX: CJ) confirms that our December dividend of $0.06 per common share will be paid on January 16, 2023 to shareholders of record on December 30, 2022. The Board of Directors of Cardinal has declared the dividend payable in cash. This dividend has been designated as an “eligible dividend” for Canadian income tax purposes. About Cardinal Energy Ltd. Cardinal works to continually improve its Environmental, Social and Governance profile and operates its assets in a responsible and environmentally sensitive manner. As part of this mandate, Cardinal injects and conserves more carbon than it directly emits making us one of the few Canadian energy companies to have a negative carbon footprint. Cardinal...

Continue reading

Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update

Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update

– Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX – Engagement with investment bank to provide advisory services including the evaluation of strategic alternatives for the Company is progressing well. – Continuing to make progress in market expansion of the current product portfolio, commercialization of the Company’s offerings, and optimization of the clinical service segment. Conference call and live webcast scheduled for tomorrow, Tuesday, December 13, 2022 at 8:30 am (ET) FARMINGDALE, N.Y., Dec. 12, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today reported operating results for the first quarter ended October 31, 2022 of Fiscal Year 2023 (Q1 FY23) and provided a business update on recent corporate and operational...

Continue reading

Fluence Energy, Inc. Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results  

Fluence Energy, Inc. Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results  

Delivered Highest Revenue in Company History & Positive Gross Margin Introduces Management’s Strategic Objectives Initiates Fiscal 2023 Financial Guidance ARLINGTON, Va., Dec. 12, 2022 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a leading global pure-play provider of energy storage products and services as well as digital applications for renewables and storage, today announced its results for the three months and fiscal year ended September 30, 2022. Highlights for fourth quarter and fiscal year ended September 30, 2022 Record revenue of $1.2 billion and $442 million for the full year and fourth quarter, respectively, representing an increase of approximately 76% from the prior full year and an increase of approximately 85% from the third quarter. GAAP gross margin improved...

Continue reading

Epiphany Technology Acquisition Corp. Announces No Contribution Will be Made to Trust Account in Connection with its Extension

Epiphany Technology Acquisition Corp. Announces No Contribution Will be Made to Trust Account in Connection with its Extension

Palo Alto, California, Dec. 12, 2022 (GLOBE NEWSWIRE) — On December 12, 2022, Epiphany Technology Acquisition Corp. (the “Company”) announced that it has filed a supplement to its definitive proxy statement (the “Proxy Statement”), dated November 29, 2022, in connection with a special meeting in lieu of an annual meeting of the stockholders (the “Meeting”) to consider and vote on certain proposals, including an extension of the date by which the Company has to complete a business combination (the “Business Combination”) from January 12, 2023 to July 12, 2023 (the “Extension”). As stated in the Proxy Statement, the Sponsor had informed the Company that it (or its designees) intended to contribute to the Company Loans of $0.04 for each public share that is not redeemed for each calendar month that is needed by the Company to complete...

Continue reading

American National Bankshares Announces the Passing  of Director, Charles Somerville Harris

American National Bankshares Announces the Passing of Director, Charles Somerville Harris

DANVILLE, Va., Dec. 12, 2022 (GLOBE NEWSWIRE) — American National Bankshares Inc. announces the unfortunate passing of Charles Somerville Harris. Mr. Harris passed away unexpectedly on December 7, 2022 in his home. Harris served as a director of American National Bankshares since 2008. He was a member of the Company’s Audit, Risk & Compliance, and Stock Grant and Option Committees. Jeffrey V. Haley, President and Chief Executive Officer of the Company and the Bank stated, “We are deeply saddened by the passing of our Director and friend. This is a big loss for us as Charles was a key member of our board who has had a lasting impact on our Company. While he was very committed to his role with American National, above all, he was an exceptional human being and we are forever grateful to him and his family for the time he shared...

Continue reading

Diamondback Energy Added to the Nasdaq – 100 Index

Diamondback Energy Added to the Nasdaq – 100 Index

MIDLAND, Texas, Dec. 12, 2022 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) announced today that it has been added to the Nasdaq-100® Index, the top 100 largest domestic and international non-financial companies on The Nasdaq based on market capitalization. Nasdaq announced the inclusion on Friday, December 9, 2022, which will become effective prior to market open on Monday, December 19, 2022. “Diamondback is proud and excited to be included in the Nasdaq-100. We have been listed on the Nasdaq exchange since the Company went public as a small cap producer in October 2012. To achieve this honor in just over ten years as a public company is a testament to our employees and their commitment to building this Company into the significant Texas-based oil producer we are today,” stated Travis Stice, Chairman...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.